Innovation Pharmaceuticals Inc (IPIX)

[TradingPro]

It’s also not for moderate to severe patients. Which is lost in the shoot first ask questions later mentality. The problem with that mentality is B results are due next week so the smarter less emotional investors are replacing the traders which is good. But there is little time to get back in. If results are good Leo I’m sure will point out the treatments are for two different patient groups. Merck’s antiviral wasn’t bad, except maybe the potential side effects. The market seemed to know the difference then and IPIX didn’t get hit too hard. Next week are results for moderate to severe patients folks. Don’t be surprised with EUA , funding, partnership, etc. because we are competing against Rem, not mild Covid patient treatments.